Hai Wang
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Oncology top 1%
- Cancer Cells and Metastasis
Papers in
-
- RNA Interference and Gene Delivery 11
- Advanced biosensing and bioanalysis techniques 9
-
- Nanoplatforms for cancer theranostics 37
- 3D Printing in Biomedical Research 10
- Co-authors
- Guangjun Nie (19 shared papers)Xiaoming He (22 shared papers)Xiongbin Lu (17 shared papers)Shuting Zhao (14 shared papers)Pranay Agarwal (16 shared papers)Can Liu (3 shared papers)Ge Gao (3 shared papers)Yongxin Zhao (3 shared papers)
- Journals
- Biomaterials (7 papers)ACS Nano (6 papers)Cancer Research (5 papers)Nature Communications (4 papers)Advanced Functional Materials (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hai Wang
244 papers receiving 9.8k citations
Hai Wang's Hit Papers
Peers
Comparison fields: 5 of 176
- Biomaterials 2.0k
- Oncology 1.7k
- Cancer Research 913
- Biomedical Engineering 2.8k
- Molecular Biology 3.5k
Countries citing papers authored by Hai Wang
This map shows the geographic impact of Hai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Wang more than expected).
Fields of papers citing papers by Hai Wang
This network shows the impact of papers produced by Hai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Wang. The network helps show where Hai Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hai Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 254 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles Hit paper breakdown → | 2011 | 523 |
| 2 | Mitochondria regulation in ferroptosis Hit paper breakdown → | 2019 | 505 |
| 3 | 2015 | 365 | |
| 4 | The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer Hit paper breakdown → | 2022 | 292 |
| 5 | 2018 | 282 | |
| 6 | 2015 | 279 | |
| 7 | Metastasis Organotropism: Redefining the Congenial Soil Hit paper breakdown → | 2019 | 271 |
| 8 | 2019 | 270 | |
| 9 | 2015 | 229 | |
| 10 | 2014 | 217 | |
| 11 | 2015 | 207 | |
| 12 | 2015 | 194 | |
| 13 | 1998 | 160 | |
| 14 | 2017 | 146 | |
| 15 | 2017 | 146 | |
| 16 | 2013 | 128 | |
| 17 | 2020 | 127 | |
| 18 | 2019 | 126 | |
| 19 | 1999 | 115 | |
| 20 | 2015 | 114 |
About Hai Wang
Hai Wang is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Biomaterials and Materials Chemistry, having authored 254 papers that have together received 9.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (37 papers), Nanoparticle-Based Drug Delivery (27 papers), Cancer Cells and Metastasis (14 papers), RNA Interference and Gene Delivery (11 papers), 3D Printing in Biomedical Research (10 papers), Advanced biosensing and bioanalysis techniques (9 papers), Tissue Engineering and Regenerative Medicine (7 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Biomaterials (2.0k citations), Oncology (1.7k citations), Cancer Research (913 citations), Biomedical Engineering (2.8k citations) and Molecular Biology (3.5k citations). Hai Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Guangjun Nie, Xiaoming He, Xiongbin Lu, Shuting Zhao, Pranay Agarwal, Can Liu, Ge Gao, Yongxin Zhao, Jianhua Yu and Yan Wu. Their work appears in journals such as Biomaterials, ACS Nano, Cancer Research, Nature Communications and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.